3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and amphetamine

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with amphetamine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (60.00)18.2507
2000's4 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kunow, M; Löschmann, PA; Wachtel, H1
Bristow, LJ; Hutson, PH; Thorn, L; Tricklebank, MD1
Bedingfield, JB; Calder, LD; Karler, R; Thai, LH2
Bespalov, AY; Zvartau, EE1
Bedingfield, JB; Calder, LD; Karler, R; Thai, DK1
Battisti, JJ; Uretsky, NJ; Wallace, LJ1
Battisti, JJ; Shreffler, CB; Uretsky, NJ; Wallace, LJ1
Billinton, A; Duxon, MS; Quinn, LP; Stean, TO; Stratton, SC; Trail, B; Upton, N1
Flores, C; Labelle-Dumais, C; Yetnikoff, L1

Other Studies

10 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and amphetamine

ArticleYear
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats.
    Neuroscience letters, 1992, Aug-17, Volume: 142, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Apomorphine; Dopamine Agents; Drug Synergism; Ibotenic Acid; Lisuride; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical

1992
Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice.
    European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3

    Topics: Amphetamine; Animals; Binding, Competitive; Corpus Striatum; Dihydroxyphenylalanine; Drug Interactions; Glycine; Male; Mice; Motor Activity; Neurons; Nucleus Accumbens; Pipecolic Acids; Piperazines; Receptors, N-Methyl-D-Aspartate

1994
The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine.
    Brain research, 1995, Feb-06, Volume: 671, Issue:1

    Topics: Amphetamine; Animals; Bicuculline; Cocaine; Dopamine Agonists; GABA Agonists; Glutamic Acid; Male; Mice; Mice, Inbred Strains; Movement; Neostriatum; Piperazines; Stereotyped Behavior; Sulpiride

1995
A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine.
    Brain research, 1994, Sep-26, Volume: 658, Issue:1-2

    Topics: Amphetamine; Animals; Cocaine; Corpus Striatum; Dizocilpine Maleate; Male; Mice; Piperazines; Quinoxalines; Receptors, Dopamine; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Sulpiride

1994
Intraaccumbens administration of NMDA receptor antagonist (+/-)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats.
    Pharmacology, biochemistry, and behavior, 1996, Volume: 55, Issue:2

    Topics: Amphetamine; Analgesics, Opioid; Animals; Central Nervous System Stimulants; Conditioning, Psychological; Excitatory Amino Acid Antagonists; Injections; Male; Morphine; Motor Activity; Nucleus Accumbens; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate

1996
The role of the striatum in the mouse in behavioral sensitization to amphetamine.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 56, Issue:2

    Topics: Amphetamine; Animals; Bicuculline; Corpus Striatum; Dopamine Antagonists; Excitatory Amino Acid Antagonists; GABA Antagonists; Male; Mice; Piperazines; Stereotyped Behavior; Sulpiride

1997
NMDA glutamate receptor role in the development of context-dependent and independent sensitization of the induction of stereotypy by amphetamine or apomorphine.
    Behavioural brain research, 2000, Volume: 114, Issue:1-2

    Topics: Amphetamine; Animals; Apomorphine; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine; Environment; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Indazoles; Male; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Piperazines; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior

2000
NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 67, Issue:2

    Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Indazoles; Male; Mice; Nitric Oxide Synthase; Piperazines; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior

2000
LABORAS: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour.
    Journal of neuroscience methods, 2003, Nov-30, Volume: 130, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Amphetamine; Angiotensin II; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Feeding Behavior; Haloperidol; Indoles; Injections, Intraventricular; Male; Motor Activity; Piperazines; Psychology, Experimental; Psychotropic Drugs; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Serotonin Antagonists; Serotonin Receptor Agonists

2003
Regulation of netrin-1 receptors by amphetamine in the adult brain.
    Neuroscience, 2007, Dec-19, Volume: 150, Issue:4

    Topics: Amphetamine; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; DCC Receptor; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Motor Activity; Nerve Growth Factors; Netrin Receptors; Netrin-1; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Tumor Suppressor Proteins; Tyrosine 3-Monooxygenase

2007